Acura Pharmaceuticals, Inc. (ACUR)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Aug 19, 2025, 4:00 PM EDT
Acura Pharmaceuticals Revenue
In the year 2021, Acura Pharmaceuticals had annual revenue of $1.56M, down -56.22%. Acura Pharmaceuticals had revenue of $36.00K in the quarter ending December 31, 2021, a decrease of -94.99%.
Revenue
1.56M
Revenue Growth
-56.22%
P/S Ratio
0.01
Revenue / Employee
173.67K
Employees
9
Market Cap
19.95K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2021 | 1.56M | -2.01M | -56.22% |
Dec 31, 2020 | 3.57M | 913.00K | 34.36% |
Dec 31, 2019 | 2.66M | 2.25M | 548.05% |
Dec 31, 2018 | 410.00K | -2.56M | -86.18% |
Dec 31, 2017 | 2.97M | -1.50M | -33.56% |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Longduoduo Company | 4.99M |
Acura Pharmaceuticals News
- 3 years ago - Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03 - GlobeNewsWire
- 3 years ago - Acura Pharmaceuticals Provides Development Update on LTX-03 - GlobeNewsWire
- 4 years ago - Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results - GlobeNewsWire
- 4 years ago - Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results - GlobeNewsWire